GT Biopharma, Inc.GTBPNASDAQ
Loading
Income Quality Over TimeContracting
Percentile Rank71
3Y CAGR-14.5%
5Y CAGR+12.2%
Year-over-Year Change
Quality of reported income
3Y CAGR
-14.5%/yr
vs +105.1%/yr prior
5Y CAGR
+12.2%/yr
Recent deceleration
Acceleration
-119.6pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.8x
Solid growth
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.46 | -53.5% |
| 2024 | 0.98 | -15.9% |
| 2023 | 1.17 | +59.9% |
| 2022 | 0.73 | +170.9% |
| 2021 | 0.27 | +4.8% |
| 2020 | 0.26 | +171.1% |
| 2019 | 0.09 | +129.8% |
| 2018 | 0.04 | +8.7% |
| 2017 | 0.04 | +141.3% |
| 2016 | -0.09 | - |